AI Drug Discovery: Can 'Future' Funding Revive Ailing Pharma?

The article highlights the financial struggles of a pharmaceutical company and its strategic move to leverage AI drug discovery for potential future gains. This reflects a broader trend of companies seeking to diversify into AI-driven areas to attract investment and address financial pressures, but the long-term viability remains uncertain, requiring careful assessment of AI implementation and return on investment.